Inducible CRISPRon or CRISPRi mouse embryo stem cells and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- TIANJIN MEDICAL UNIV
- Publication Date
- 2017-09-08
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of gene expression regulation, in particular to an inducible CRISPRon and CRISPRi mouse embryonic stem cell and its application. Background technique
[0002] RNA interference (RNAi) or gene overexpression (overexpression, OE) is a common method for gene function research. However, RNAi is a post-transcriptional regulation and is prone to off-target phenomena; overexpression (OE) often uses the promoter of the cloning vector to promote the expression of foreign genes, and the activity of the promoter is unstable and uncontrollable in different cell types.
[0003] The combination of regularly clustered interspaced short palindromic repeats CRISPR and endonuclease Cas9 can target and cut the DNA genetic material of invaders under the guidance of guide RNA (sgRNA). In 2012, researchers took advantage of this feature to make the CRISPR system into a powerful genome editing tool (Jinek, M. et al., 2012; Cong, L. et al., ...